International Journal of Clinical Cardiology最新文献

筛选
英文 中文
Middle Aortic Syndrome Presented in Pregnancy-Treated with Percutaneous Intervention Followed by Successful Management of the Complications 妊娠期出现中主动脉综合征--经皮介入治疗后成功控制并发症
International Journal of Clinical Cardiology Pub Date : 2024-03-31 DOI: 10.23937/2378-2951/1410292
Niari Jayakrishna, Gutte Avinash A, Waghmare Nagesh, Munde Kalyan S, Mutha Samkit, Kolapkar Hariom
{"title":"Middle Aortic Syndrome Presented in Pregnancy-Treated with Percutaneous Intervention Followed by Successful Management of the Complications","authors":"Niari Jayakrishna, Gutte Avinash A, Waghmare Nagesh, Munde Kalyan S, Mutha Samkit, Kolapkar Hariom","doi":"10.23937/2378-2951/1410292","DOIUrl":"https://doi.org/10.23937/2378-2951/1410292","url":null,"abstract":"Introduction: Mid-aortic syndrome is a clinical condition characterized by segmental narrowing of the abdominal or descending thoracic aorta, often resulting in severe hypertension. It can manifest as either a congenital abnormality or as one of several acquired conditions. Given the limited evidence available on the treatment of this syndrome, various approaches have been reported, including surgical intervention and endovascular treatments such as stent placement and medical management alone. Objective: To determine the prevalence of ACS patients and the risk factors of in-hospital mortality of STEMI patients at Bekasi District General Hospital in 2021. Case presentation: We present the case of a 21-year-old female who developed life-threatening hypertension during the 21st week of pregnancy, a condition that went unrecognized before gestation due to the rarity of this syndrome. Unfortunately, in our patient, arterial hypertension proved resistant to a 4-drug antihypertensive regimen and there is evidence of end organ damage and fetal compromise. However following termination of pregnancy, a successful endovascular repair of mid-aortic syndrome was achieved using a self-expanding stent, along with bilateral renal artery stenting. Following the procedure, patient developed haemorrhagic stroke which was managed successfully and patient discharged in a stable condition. Conclusion: Patient is doing well for the last 11 months. Mid-aortic syndrome presented in pregnancy can be successfully managed with percutaneous intervention.","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"21 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140359708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Risk Factors of In-Hospital Mortality of ST Elevation Myocardial Infarction (STEMI) Patients during January-December 2021 at Bekasi District General Hospital 2021 年 1 月至 12 月期间贝卡西地区综合医院 STEV 心肌梗死 (STEMI) 患者院内死亡率的发生率和风险因素
International Journal of Clinical Cardiology Pub Date : 2024-03-31 DOI: 10.23937/2378-2951/1410291
Syauqi Khanza Rizqullah, Akhmad Mailani Karina, Siregar Omar Mokhtar
{"title":"Prevalence and Risk Factors of In-Hospital Mortality of ST Elevation Myocardial Infarction (STEMI) Patients during January-December 2021 at Bekasi District General Hospital","authors":"Syauqi Khanza Rizqullah, Akhmad Mailani Karina, Siregar Omar Mokhtar","doi":"10.23937/2378-2951/1410291","DOIUrl":"https://doi.org/10.23937/2378-2951/1410291","url":null,"abstract":"Background: Acute coronary syndrome (ACS) is a major cardiovascular problem. According to the World Health Organization (WHO) in 2015, cardiovascular disease caused 17.5 million deaths, while ACS caused 7.4 million deaths. ACS is a condition when the plaques are accumulated in coronary arteries that supply oxygen to the heart muscles. The ST-Elevation Myocardial Infarction (STEMI) is an indicator of total coronary artery occlusion. This condition requires revascularization to restore blood flow and myocardial reperfusion using fibrinolytic agents or primary Percutaneous Coronary Intervention (PCI). Early reperfusion therapy can reduce in-hospital mortality and show better outcomes in ACS patients. Objective: To determine the prevalence of ACS patients and the risk factors of in-hospital mortality of STEMI patients at Bekasi District General Hospital in 2021. Methods: This research was a descriptive cross-sectional study using secondary data from medical records. The data were presented in diagrams and tables. Results: There were 117 cases of ACS in 2021. They were 14% STEMI, 15% Non-ST Elevation Myocardial Infarction (NSTEMI), and 71% Unstable Angina Pectoris (UAP). Most patients were male (54%), and aged < 65-years-old (85%). The in-hospital mortality was 19% STEMI, 17% NSTEMI, and 12% UAP. Among 16 STEMI patients, 81% were male and 94% were aged < 65-years-old. There were 69% who came to the emergency room < 12 hours and only 50% underwent fibrinolytic. Conclusion: The risk factors of in-hospital mortality of STEMI patients were 40% late onset, 23% anterior STEMI, 20% hypertension, 60% diabetes mellitus, 50% chronic kidney disease, 33% tachycardia, and 100% Killip III.","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"7 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140359327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dengue Myocarditis with Gitelman Syndrome Presenting as Arrhythmic Syncope: A Case Report of Acute Fulminant Dengue Myocarditis Resulting to Acquired Long QT Syndrome 登革热心肌炎合并 Gitelman 综合征,表现为心律失常性晕厥:导致获得性长 QT 综合征的急性暴发性登革热心肌炎病例报告
International Journal of Clinical Cardiology Pub Date : 2024-02-28 DOI: 10.23937/2378-2951/1410289
David Billy Joseph, Maderazo Donna Aurea, Gaspar-Cabrera Dianne Camille, Castro Rod
{"title":"Dengue Myocarditis with Gitelman Syndrome Presenting as Arrhythmic Syncope: A Case Report of Acute Fulminant Dengue Myocarditis Resulting to Acquired Long QT Syndrome","authors":"David Billy Joseph, Maderazo Donna Aurea, Gaspar-Cabrera Dianne Camille, Castro Rod","doi":"10.23937/2378-2951/1410289","DOIUrl":"https://doi.org/10.23937/2378-2951/1410289","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"28 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140419865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fever-Induced Brugada Syndrome (BrS): Clinical Case Presentation and Short Review on Brugada Syndrome 热致Brugada综合征(BrS):临床病例报告和Brugada综合征的简短回顾
International Journal of Clinical Cardiology Pub Date : 2023-09-30 DOI: 10.23937/2378-2951/1410277
Kassier Almontasser Bella, Kassier Adnan, Agrawal Yashwant, Kalavakunta Jagadeesh
{"title":"Fever-Induced Brugada Syndrome (BrS): Clinical Case Presentation and Short Review on Brugada Syndrome","authors":"Kassier Almontasser Bella, Kassier Adnan, Agrawal Yashwant, Kalavakunta Jagadeesh","doi":"10.23937/2378-2951/1410277","DOIUrl":"https://doi.org/10.23937/2378-2951/1410277","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123714782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atrial Flutter as the Primary Manifestation of Lupus Flare Up 心房扑动是狼疮发作的主要表现
International Journal of Clinical Cardiology Pub Date : 2023-08-31 DOI: 10.23937/2378-2951/1410279
Bansro Varinder, Birhane Tekabe, Gurbakhshani Marvi, Gichamo Fregenet, Unamba Uchenna
{"title":"Atrial Flutter as the Primary Manifestation of Lupus Flare Up","authors":"Bansro Varinder, Birhane Tekabe, Gurbakhshani Marvi, Gichamo Fregenet, Unamba Uchenna","doi":"10.23937/2378-2951/1410279","DOIUrl":"https://doi.org/10.23937/2378-2951/1410279","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114671143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uric Acid as a Novel Component of Metabolic Syndrome 尿酸作为代谢综合征的新组成部分
International Journal of Clinical Cardiology Pub Date : 2023-06-30 DOI: 10.23937/2378-2951/1410278
Bowden Rodney G, Richardson Kathleen A, Richardson Luke T
{"title":"Uric Acid as a Novel Component of Metabolic Syndrome","authors":"Bowden Rodney G, Richardson Kathleen A, Richardson Luke T","doi":"10.23937/2378-2951/1410278","DOIUrl":"https://doi.org/10.23937/2378-2951/1410278","url":null,"abstract":"Objective: Uric continues to be explored as a novel risk factor for Metabolic Syndrome. The purpose of our study was to identify risk factors that are associated with hyperuricemia and to better understand if uric acid might serve as a useful component of metabolic syndrome. Methods: A cross-sectional data analysis was conducted using the 2013-2018 NHANES datasets. Sample weights were assigned by NHANES researchers to each participant allowing researchers to generalize results to all non-institutionalized US civilians. The analysis included 6,432 individuals, which were representative of 94,729,059 US citizens. Results: We demonstrated that the risk factors that had a statistically significant relationship with UA value were fasting glucose, triglycerides, systolic BP, and waist circumference. Fasting blood glucose had an inverse relationship with UA level, indicating that for every 1-point increase in fasting blood glucose, uric acid level decreased slightly. The most adjusted model reports HDL also demonstrated an inverse relationship with UA but this relationship was attenuated after controlling for potential confounders. Triglyceride level, systolic BP, and WC had direct relationships with UA level, indicating that as each risk factor increased, UA level also increased. Waist circumference had the greatest clinical significance for UA level. Conclusions: The findings from our study suggest that metabolic syndrome risk factors do have a relationship with UA level, both in the total population and in those with metabolic syndrome. We found general trends that indicated that fasting blood glucose and HDL had negative relationships with UA level, whereas triglycerides, systolic BP, and waist circumference have positive relationships with UA. Diastolic BP did not demonstrate a relationship with UA level, and the relationship between HDL and UA was attenuated after adjustment for confounding variables. The findings suggest a need to further explore UA as a novel risk factor for metabolic syndrome.","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129757254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-Uremic Calciphylaxis in Patient of Non Recovered Postpartum Cardiomyopathy with Apla Syndrome 未恢复的产后心肌病伴Apla综合征患者的非尿毒症性钙化治疗
International Journal of Clinical Cardiology Pub Date : 2023-06-30 DOI: 10.23937/2378-2951/1410275
Makhija Aman, Vanani Jignesh, Mohanty Arun, S. Manchanda, Dhawan Shashi, Garg Shilpa, Malik Manish, R. Mantri
{"title":"Non-Uremic Calciphylaxis in Patient of Non Recovered Postpartum Cardiomyopathy with Apla Syndrome","authors":"Makhija Aman, Vanani Jignesh, Mohanty Arun, S. Manchanda, Dhawan Shashi, Garg Shilpa, Malik Manish, R. Mantri","doi":"10.23937/2378-2951/1410275","DOIUrl":"https://doi.org/10.23937/2378-2951/1410275","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"164 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127303271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Performance Enhancement Drugs on Body Mass Index, Blood Pressure, and Blood Sugar Levels on a Healthy Adult Male: A Case Study 成绩增强药物对健康成年男性体重指数、血压和血糖水平的影响:个案研究
International Journal of Clinical Cardiology Pub Date : 2023-04-30 DOI: 10.23937/2378-2951/1410274
Villarino Resti Tito H, Villarino Maureen Lorence F
{"title":"Effects of Performance Enhancement Drugs on Body Mass Index, Blood Pressure, and Blood Sugar Levels on a Healthy Adult Male: A Case Study","authors":"Villarino Resti Tito H, Villarino Maureen Lorence F","doi":"10.23937/2378-2951/1410274","DOIUrl":"https://doi.org/10.23937/2378-2951/1410274","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122825065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Novel Active Fixation Left Ventricular Leads and Conventional Passive Fixation Leads in Cardiac Resynchronization Therapy 新型主动固定左心室导联与传统被动固定导联在心脏再同步化治疗中的影响
International Journal of Clinical Cardiology Pub Date : 2023-02-28 DOI: 10.23937/2378-2951/1410273
Takano Makoto, Matsuda Hisao, Harada Tomoo, Akashi Yoshihiro J
{"title":"The Impact of Novel Active Fixation Left Ventricular Leads and Conventional Passive Fixation Leads in Cardiac Resynchronization Therapy","authors":"Takano Makoto, Matsuda Hisao, Harada Tomoo, Akashi Yoshihiro J","doi":"10.23937/2378-2951/1410273","DOIUrl":"https://doi.org/10.23937/2378-2951/1410273","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123020451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
siRNA-Induced Silencing of LP(a) Gene: An Ideal Choice to Prevent Genetic Risk of Myocardial Infarction sirna诱导LP(a)基因沉默:预防心肌梗死遗传风险的理想选择
International Journal of Clinical Cardiology Pub Date : 2022-12-31 DOI: 10.23937/2378-2951/1410271
Arslan Muhammad
{"title":"siRNA-Induced Silencing of LP(a) Gene: An Ideal Choice to Prevent Genetic Risk of Myocardial Infarction","authors":"Arslan Muhammad","doi":"10.23937/2378-2951/1410271","DOIUrl":"https://doi.org/10.23937/2378-2951/1410271","url":null,"abstract":"","PeriodicalId":112011,"journal":{"name":"International Journal of Clinical Cardiology","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128042834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信